SecBot SecBot
8-K ·Filed Oct 13, 2026
TR

TRFA

TRAFALGAR INTERNATIONAL, INC.
NEUTRAL
Impact 3/10
Horizonweeks Processed12d 17h ago SEC0001493152-26-046901
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

The governance changes entrench Series B voting control and eliminate all conversion rights for both preferred series. Monitor the Schedule 14C filing for shareholder consent details and any subsequent capital structure actions that may affect common equity.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+5d
TRFA ▼ -34.21% at T+5d
NEUTRAL call -34.21% · α vs SPY -34.66% · entry $1.14 → $0.7500
Next anchor: T+20d in 15d
Latest observation: T+7 -2.67% FF3 residual α
Entry = T+0 close
Oct 13, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.28%
$1.14
settled 12d ago
T+5d
-34.21%
call -34.21% · α -34.66%
$0.7500
settled 6d ago
T+20d
Pending
in 15d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Trafalgar International filed an 8-K to adopt Amended and Restated Articles of Incorporation, which comprehensively restate the company's charter with significant changes to its capital stock. The new articles eliminate all conversion rights for Series A and Series B Preferred Stock, remove voting rights for Series A, and grant Series B a permanent 51% aggregate voting control over all shareholder matters on a fully diluted basis. The filing is a routine governance update with no financial data or operational changes.

Key Facts

  • Board approved Amended and Restated Articles of Incorporation on October 12, 2026.
  • Authorized capital: 2,000,000,000 shares of Common Stock, $0.001 par value; 20,000,000 shares of Preferred Stock, $0.001 par value.
  • Series A Preferred Stock (10,000,000 shares) loses all voting rights and conversion rights; no dividends or liquidation preference.
  • Series B Preferred Stock (1,000 shares) granted permanent 51% aggregate voting control on all shareholder matters, calculated on a fully diluted basis.
  • Series B has a $1.00 per share liquidation preference and protective consent rights over charter amendments, new voting securities, and mergers.
  • No shareholder meeting will be held; action taken via written consent and Schedule 14C information statement.
  • No securities are registered under Section 12(b) of the Exchange Act; no trading symbol listed.

Financial Impact

No financial figures disclosed; governance restructuring only.

Risk Factors

  • Permanent 51% voting control by Series B could disenfranchise common shareholders on key matters.
  • Elimination of conversion rights for preferred shares removes potential equity upside for those holders.
  • No financial data or operational updates provided; limited trading information available.

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-046901
Exhibit: ex3-1.htm0001493152-26-046901
Document: 0001493152-26-046901-index-headers.html0001493152-26-046901
Document: 0001493152-26-046901-index.html0001493152-26-046901
Document: 0001493152-26-046901.txt0001493152-26-046901

US Market Status

Market Open — Closes in 4h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 13, 2026